Last10K.com

Applied Genetic Technologies Corp (AGTC) SEC Filing 8-K Material Event for the period ending Tuesday, November 30, 2021

Applied Genetic Technologies Corp

CIK: 1273636 Ticker: AGTC

View differences made from one to another to evaluate Applied Genetic Technologies Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Applied Genetic Technologies Corp.

Continue

Assess how Applied Genetic Technologies Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Applied Genetic Technologies Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Applied Genetic Technologies Corp provided additional information to their SEC Filing as exhibits

Ticker: AGTC
CIK: 1273636
Form Type: 8-K Corporate News
Accession Number: 0001193125-21-348474
Submitted to the SEC: Mon Dec 06 2021 8:11:01 AM EST
Accepted by the SEC: Mon Dec 06 2021
Period: Tuesday, November 30, 2021
Industry: Biological Products No Disgnostic Substances
Events:
  1. Event for Officers
  2. Financial Exhibit
  3. Vote of Security Holders

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/agtc/0001193125-21-348474.htm